NBSE

NeuBase Therapeutics, Inc. Common Stock

Delisted

NBSE was delisted on the 10th of May, 2024.

19 hedge funds and large institutions have $177K invested in NeuBase Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$14.2K
2 +$563
3 +$56
Name Holding Trade Value Shares
Change
Change in
Stake
1
$61.3K
2
$40K
3
$28.1K
4
$21.1K
5
$8.54K
6
$7K
7
$6.84K
8
$1.82K
9
$1.16K
10
$563
11
$361
12
$158
13
$35
14
$10
15
$9
16
$5
17
$4
18
19
20
21